Skip to content

Adagene vs OncoResponse

Adagene logo

Adagene

Redefining the design and discovery of therapeutic antibodies

81 employees · est. 2012

VS
OncoResponse logo

OncoResponse

Interrogating for Cures

10 employees · est. 2016 · Houston, United States

Adagene is the older company (2012 vs 2016); Adagene is the larger of the two.

Side-by-Side Comparison

Adagene OncoResponse
Founded
2012 older 2016
Headquarters
Not tracked yet Houston, United States
Employees
81 larger 10
Industry
Biotechnology, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
IPO Not tracked yet
Total Funding
$390.00M $117.10M
Funding Rounds
8 6
Services
Antibody Discovery, Antibody Engineering, Drug Development Development of novel cancer immunotherapies, Discovery of human antibodies, Partnering with collaborators in immuno-oncology, Preclinical studies
Target Customers
Pharmaceutical Companies, Healthcare Institutions, Biotech Investors Biopharmaceutical companies, Oncology researchers, Cancer patients, Clinical study collaborators
Taxonomy
Antibody DiscoveryCancer ImmunotherapyComputational BiologyDPL PlatformNEObody TechnologySAFEbody Technology +7 Immuno-oncologyBiotechCancer ImmunotherapyAntibody PlatformB-cell DiscoveryTumor Microenvironment +8
Website
adagene.com oncoresponse.com
Adagene logo

About Adagene

Adagene Inc. (Nasdaq: ADAG) is a pioneering biotechnology company established in 2012, with a commitment to transforming the design and discovery of antibody-based cancer immunotherapies. The company’s slogan, "Redefining the design and discovery of therapeutic antibodies," underscores its innovativ...

OncoResponse logo

About OncoResponse

OncoResponse, founded in 2016, is an innovative player in the immuno-oncology biotech sector. This biopharma company is particularly notable for its strategic collaboration with the MD Anderson Cancer Center, which amplifies its capabilities in treating cancer. Utilizing a proprietary B-cell discov...

Also comparing in this category

Comparing more than these two?

Get Adagene, OncoResponse and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Adagene compare?

A PDF of Adagene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Adagene was founded in 2012, with 81 employees. Adagene Inc. (Nasdaq: ADAG) is a pioneering biotechnology company established in 2012, with a commitment to transforming the design and discovery of antibody-based cancer immunotherapies. The company’. OncoResponse was founded in 2016, based in Houston, United States, with 10 employees. OncoResponse, founded in 2016, is an innovative player in the immuno-oncology biotech sector. This biopharma company is particularly notable for its strategic collaboration with the MD Anderson Cancer.
Adagene has raised $390.00M and OncoResponse $117.10M. Latest stage: Adagene IPO.
Both work in Biotechnology and Health and Wellness and list cancer immunotherapy and immuno-oncology among their focus areas.

Compare Adagene with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Adagene on 15 Jun 2026, and OncoResponse on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout